Geoffrey Bailhache~~Paul Foote~~Étienne Renaudeau~~Pauline Patat
January 24, 2026
Blackstone Announces Investment in Lazeo

1 min
AI-made summary
- The Firm, acting as co-counsel with Bredin Prat, is advising Blackstone on its agreement to make a significant investment in Lazeo, a leading provider of aesthetic medicine services in France
- The transaction, which is subject to customary regulatory approvals, aims to support Lazeo’s growth and expansion
- Lazeo, founded in 2010 in Paris, operates 135 locations in France, five in Belgium, and recently expanded into Germany with the acquisition of Cleanskin.
The Firm is serving as co-counsel, alongside Bredin Prat, to Blackstone in connection with its agreement to make a significant investment in Lazeo, the number one provider of aesthetic medicine services in France. The partnership will support Lazeo’s continued growth and help meaningfully scale its operations and ongoing expansion. The transaction is conditional on customary regulatory clearances.
Headquartered in Paris, Lazeo is a founder-led, family-owned provider of non-invasive aesthetic medicine services including laser hair removal, injectables, body contouring and medical-grade facials. Founded in 2010 by Dr. Bernard and Dimitri Sillam with a single location in Paris, Lazeo has grown to become the number one provider in France with 135 locations, five in Belgium and significant runway for further expansion in both existing and new markets. In 2023, Lazeo entered Germany with the acquisition of Munich-based Cleanskin.
The Simpson Thacher team includes Geoff Bailhache and Paul Foote (Corporate); and Étienne Renaudeau and Pauline Patat (Antitrust).
Article Author
Geoffrey Bailhache~~Paul Foote~~Étienne Renaudeau~~Pauline Patat
The Sponsor
